Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy

Deficiency in DNA damage response (DDR) genes leads to impaired DNA repair functions that will induce genomic instability and facilitate cancer development. However, alterations of DDR genes can serve as biomarkers for the selection of suitable patients to receive specific therapeutics, such as immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jau-Ling, Chang, Yu-Tzu, Hong, Zhen-Yang, Lin, Chang-Shen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952261/
https://www.ncbi.nlm.nih.gov/pubmed/35328658
http://dx.doi.org/10.3390/ijms23063238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952261/
https://www.ncbi.nlm.nih.gov/pubmed/35328658
http://dx.doi.org/10.3390/ijms23063238

Ejemplares similares